采用共沉淀法制备LiNi1/3Co1/3Mn1/3O2正极材料,并用聚苯胺(PANI)对材料进行表面包覆。通过XRD、SEM和透射电子显微镜(TEM),对材料的结构和形貌进行分析;采用恒流充放电、循环伏安和交流阻抗测试,研究包覆量对材料电化学性能的影响。当P...采用共沉淀法制备LiNi1/3Co1/3Mn1/3O2正极材料,并用聚苯胺(PANI)对材料进行表面包覆。通过XRD、SEM和透射电子显微镜(TEM),对材料的结构和形貌进行分析;采用恒流充放电、循环伏安和交流阻抗测试,研究包覆量对材料电化学性能的影响。当PANI包覆量为10%时,LiNi1/3Co1/3Mn1/3O2正极材料的电化学性能最好,以1 C在2.5~4.6 V循环,放电比容量为185.0 m Ah/g,比未包覆PANI的材料提高13.8%。展开更多
本文分别以天然石墨(NG)、人造石墨(AG)和中间相碳微球(MCMB)为负极材料,制备了三种不同的方形三元(LiNi1/3Co1/3Mn1/3O2)动力电池。通过多种手段测试了各动力电池的电化学性能。结果显示,三元/中间相碳微球(LNCM/MCMB)电池表现出较为...本文分别以天然石墨(NG)、人造石墨(AG)和中间相碳微球(MCMB)为负极材料,制备了三种不同的方形三元(LiNi1/3Co1/3Mn1/3O2)动力电池。通过多种手段测试了各动力电池的电化学性能。结果显示,三元/中间相碳微球(LNCM/MCMB)电池表现出较为优异的电化学高低温、倍率和循环性能,其在?20℃及55℃下的1C容量保持率分别为84.94%和101.99%,4C高倍率容量保持率为 100.11%,1 C 循环1000次后容量保持率为94.01%。展开更多
采用活性炭吸附含Co^(2+),Mn^(2+),Ni^(2+)和Li^+的乙酸盐混合溶液,辅以高温热处理制备了碳包覆LiNi_(1/3)Co_(1/3)Mn_(1/3)O2(NCM@C).透射电子显微镜(TEM)观测结果表明,碳包覆层的厚度约为10 nm.电化学性能测试结果表明,在0.2C下首次...采用活性炭吸附含Co^(2+),Mn^(2+),Ni^(2+)和Li^+的乙酸盐混合溶液,辅以高温热处理制备了碳包覆LiNi_(1/3)Co_(1/3)Mn_(1/3)O2(NCM@C).透射电子显微镜(TEM)观测结果表明,碳包覆层的厚度约为10 nm.电化学性能测试结果表明,在0.2C下首次放电比容量为181 m A·h/g,首次充放电效率为90.7%;在20C倍率下,NCM@C仍具有78 m A·h/g的放电比容量,而采用溶胶凝胶法制备的Li Ni_(1/3)Co_(1/3)Mn_(1/3)O2(NCM)的比容量仅为39 m A·h/g;NCM@C还表现出良好的循环稳定性,在0.2C倍率下循环50周容量保持率为88.1%,而NCM容量保持率仅为66.4%.展开更多
BACKGROUND The TGF-β/SMAD3 and VEGFR-1 signaling pathways play important roles in gastric cancer metastasis.SMAD3 phosphorylation is a crucial prognostic marker in gastric cancer.AIM To determine the prognostic value...BACKGROUND The TGF-β/SMAD3 and VEGFR-1 signaling pathways play important roles in gastric cancer metastasis.SMAD3 phosphorylation is a crucial prognostic marker in gastric cancer.AIM To determine the prognostic value and relationship of SMAD3 phospho-isoforms and VEGFR-1 in gastric cancer.METHODS This was a single-center observational study which enrolled 98 gastric cancer patients and 82 adjacent normal gastric tissues from patients aged 32-84 years(median age 65)between July 2006 and April 2007.Patients were followed up until death or the study ended(median follow-up duration of 28.5 mo).The samples were used to generate tissue microarrays(TMAs)for immunohistochemical(IHC)staining.The expressions of TGF-β1,pSMAD3C(S423/425),pSMAD3L(S204),and VEGFR-1 in gastric cancer(GC)tumor tissue and normal tissue were measured by IHC staining using TMAs obtained from 98 GC patients.Prognosis and survival information of the patients was recorded by Outdo Biotech from May 2007 to July 2015.The relationship between TGF-β1,pSMAD3C(S423/425),pSMAD3L(S204),and VEGFR-1 protein expression levels was analyzed using Pearson's correlation coefficient.The relationship between protein expression levels and clinicopathological parameters was analyzed using the Chi-squared test.A survival curve was generated using the Kaplan-Meier survival analysis.RESULTS TGFβ-1 and VEGFR-1 expression was significantly upregulated in gastric cancer tissue compared to adjacent noncancerous tissue.The positive expression of phosphorylated isoforms of Smad3 varied depending on the phosphorylation site[pSMAD3C(S423/425):51.0%and pSMAD3L(S204):31.6%].High expression of pSMAD-3L(S204)was significantly correlated with larger tumors(P=0.038)and later N stages(P=0.035).Additionally,high expression of VEGFR-1 was closely correlated with tumor size(P=0.015)and pathological grading(P=0.013).High expression of both pSMAD3L(S204)and VEGFR-1 was associated with unfavorable outcomes in terms of overall survival(OS).Multivariate analysis indicated that high expression of pSMAD3L(S204)and VEGFR-1 were independent risk factors for prognosis in GC patients.VEGFR-1 protein expression was correlated with TGF-β1(r=0.220,P=0.029),pSMAD3C(S423/425)(r=0.302,P=0.002),and pSMAD3L(S204)(r=0.201,P=0.047),respectively.Simultaneous overexpression of pSMAD3L(S204)and VEGFR-1 was associated with poor OS in gastric cancer patients.CONCLUSION Co-upregulation of pSMAD3L(S204)and VEGFR-1 can serve as a predictive marker for poor gastric cancer prognosis,and pSMAD3L(204)may be involved in enhanced gastric cancer metastasis in a VEGFR-1-dependent manner.展开更多
BACKGROUND The dysregulation of tissue inhibitor of metalloproteinase-3(TIMP3)was positively correlated with the progression of hepatocellular carcinoma(HCC).However,it is not clear whether TIMP3 expression is associa...BACKGROUND The dysregulation of tissue inhibitor of metalloproteinase-3(TIMP3)was positively correlated with the progression of hepatocellular carcinoma(HCC).However,it is not clear whether TIMP3 expression is associated with the clinico-pathological features and prognosis of aflatoxin B1(AFB1)-related HCC(AHCC).A retrospective study,including 182 patients with AHCC,was conducted to explore the link between TIMP3 expression in cancerous tissues and the clinico-pathological characteristics and prognosis of AHCC.TIMP3 expression was detected by immunohistochemistry and its effects on the clinicopathological features and prognosis of AHCC were evaluated by Kaplan-Meier survival analysis and Cox regression survival analysis.Odds ratio,hazard ratio(HR),median overall survival time(MST),median tumor recurrence-free survival time(MRT),and corresponding 95%confidential interval(CI)was calculated to RESULTS Kaplan-Meier survival analysis showed that compared with high TIMP3 expression,low TIMP3 expression in tumor tissues significantly decreased the MST(36.00 mo vs 18.00 mo)and MRT(32.00 mo vs 16 mo)of patients with AHCC.Multivariate Cox regression survival analysis further proved that decreased expression of TIMP3 increased the risk of death(HR=2.85,95%CI:2.04-4.00)and tumor recurrence(HR=2.26,95%CI:1.57-3.26).Furthermore,decreased expression of TIMP3 protein in tissues with AHCC was significantly correlated with tumor clinicopatho-logical features,such as tumor size,tumor grade and stage,tumor microvessel density,and tumor blood invasion.Additionally,TIMP3 protein expression was also negatively associated with amount of AFB1-DNA adducts in tumor tissues.CONCLUSION These findings indicate that the dysregulation of TIMP3 expression is related to AHCC biological behaviors and affects tumor outcome,suggesting that TIMP3 may act as a prognostic biomarker for AHCC.展开更多
基金supported by the National Natural Science Foundation of China(Nos.51874196,51674164)the Program for Professor of Special Appointment at the Shanghai Institutions of Higher Learning,China(No.TP2020032)+2 种基金the Iron and Steel Joint Research Fund of the National Natural Science Foundation of China and China Baowu Steel Group Corp.Ltd.(No.U1860203)the Independent Research and Development Project of State Key Laboratory of Advanced Special Steel,Shanghai Key Laboratory of Advanced Ferrometallurgy,Shanghai University,China(No.SKLASS 2021-Z03)the Science and Technology Commission of Shanghai Municipality,China(Nos.21DZ1208900,19DZ2270200,20511107700)。
文摘采用共沉淀法制备LiNi1/3Co1/3Mn1/3O2正极材料,并用聚苯胺(PANI)对材料进行表面包覆。通过XRD、SEM和透射电子显微镜(TEM),对材料的结构和形貌进行分析;采用恒流充放电、循环伏安和交流阻抗测试,研究包覆量对材料电化学性能的影响。当PANI包覆量为10%时,LiNi1/3Co1/3Mn1/3O2正极材料的电化学性能最好,以1 C在2.5~4.6 V循环,放电比容量为185.0 m Ah/g,比未包覆PANI的材料提高13.8%。
文摘本文分别以天然石墨(NG)、人造石墨(AG)和中间相碳微球(MCMB)为负极材料,制备了三种不同的方形三元(LiNi1/3Co1/3Mn1/3O2)动力电池。通过多种手段测试了各动力电池的电化学性能。结果显示,三元/中间相碳微球(LNCM/MCMB)电池表现出较为优异的电化学高低温、倍率和循环性能,其在?20℃及55℃下的1C容量保持率分别为84.94%和101.99%,4C高倍率容量保持率为 100.11%,1 C 循环1000次后容量保持率为94.01%。
文摘采用活性炭吸附含Co^(2+),Mn^(2+),Ni^(2+)和Li^+的乙酸盐混合溶液,辅以高温热处理制备了碳包覆LiNi_(1/3)Co_(1/3)Mn_(1/3)O2(NCM@C).透射电子显微镜(TEM)观测结果表明,碳包覆层的厚度约为10 nm.电化学性能测试结果表明,在0.2C下首次放电比容量为181 m A·h/g,首次充放电效率为90.7%;在20C倍率下,NCM@C仍具有78 m A·h/g的放电比容量,而采用溶胶凝胶法制备的Li Ni_(1/3)Co_(1/3)Mn_(1/3)O2(NCM)的比容量仅为39 m A·h/g;NCM@C还表现出良好的循环稳定性,在0.2C倍率下循环50周容量保持率为88.1%,而NCM容量保持率仅为66.4%.
基金Supported by National Nature Science Foundation of China,No.82060450,No.82360517,No.81460374,and No.31460304Nature Science Foundation of Jiangxi Province of China,No.20232BAB206086,No.20192BAB205072,No.20203BBGL73206,No.2017BCB23086,No.2017BAB205062,and No.20181BAB205050.
文摘BACKGROUND The TGF-β/SMAD3 and VEGFR-1 signaling pathways play important roles in gastric cancer metastasis.SMAD3 phosphorylation is a crucial prognostic marker in gastric cancer.AIM To determine the prognostic value and relationship of SMAD3 phospho-isoforms and VEGFR-1 in gastric cancer.METHODS This was a single-center observational study which enrolled 98 gastric cancer patients and 82 adjacent normal gastric tissues from patients aged 32-84 years(median age 65)between July 2006 and April 2007.Patients were followed up until death or the study ended(median follow-up duration of 28.5 mo).The samples were used to generate tissue microarrays(TMAs)for immunohistochemical(IHC)staining.The expressions of TGF-β1,pSMAD3C(S423/425),pSMAD3L(S204),and VEGFR-1 in gastric cancer(GC)tumor tissue and normal tissue were measured by IHC staining using TMAs obtained from 98 GC patients.Prognosis and survival information of the patients was recorded by Outdo Biotech from May 2007 to July 2015.The relationship between TGF-β1,pSMAD3C(S423/425),pSMAD3L(S204),and VEGFR-1 protein expression levels was analyzed using Pearson's correlation coefficient.The relationship between protein expression levels and clinicopathological parameters was analyzed using the Chi-squared test.A survival curve was generated using the Kaplan-Meier survival analysis.RESULTS TGFβ-1 and VEGFR-1 expression was significantly upregulated in gastric cancer tissue compared to adjacent noncancerous tissue.The positive expression of phosphorylated isoforms of Smad3 varied depending on the phosphorylation site[pSMAD3C(S423/425):51.0%and pSMAD3L(S204):31.6%].High expression of pSMAD-3L(S204)was significantly correlated with larger tumors(P=0.038)and later N stages(P=0.035).Additionally,high expression of VEGFR-1 was closely correlated with tumor size(P=0.015)and pathological grading(P=0.013).High expression of both pSMAD3L(S204)and VEGFR-1 was associated with unfavorable outcomes in terms of overall survival(OS).Multivariate analysis indicated that high expression of pSMAD3L(S204)and VEGFR-1 were independent risk factors for prognosis in GC patients.VEGFR-1 protein expression was correlated with TGF-β1(r=0.220,P=0.029),pSMAD3C(S423/425)(r=0.302,P=0.002),and pSMAD3L(S204)(r=0.201,P=0.047),respectively.Simultaneous overexpression of pSMAD3L(S204)and VEGFR-1 was associated with poor OS in gastric cancer patients.CONCLUSION Co-upregulation of pSMAD3L(S204)and VEGFR-1 can serve as a predictive marker for poor gastric cancer prognosis,and pSMAD3L(204)may be involved in enhanced gastric cancer metastasis in a VEGFR-1-dependent manner.
基金the Science-Technology Planning Project of Guangxi,No.Guike-AD19245174Guangxi Training Program for Medical High-level Academic Leaders,No.6 of Guiweikejiaofa[2020]-15+3 种基金Bose Talent Highland,No.2020-3-2Building Projects from the Key Laboratory of Molecular Pathology(Hepatobiliary Diseases)of Guangxi,No.Guiweikejiaofa[2020]-17the Key Laboratory of Tumor Molecular Pathology of Guangxi Colleges and Universities,No.Guijiaokeyan[2022]-10and Clinical Key Specialty Building Project(For Pathology)of Guangxi,No.Guiweiyifa[2022]-21.
文摘BACKGROUND The dysregulation of tissue inhibitor of metalloproteinase-3(TIMP3)was positively correlated with the progression of hepatocellular carcinoma(HCC).However,it is not clear whether TIMP3 expression is associated with the clinico-pathological features and prognosis of aflatoxin B1(AFB1)-related HCC(AHCC).A retrospective study,including 182 patients with AHCC,was conducted to explore the link between TIMP3 expression in cancerous tissues and the clinico-pathological characteristics and prognosis of AHCC.TIMP3 expression was detected by immunohistochemistry and its effects on the clinicopathological features and prognosis of AHCC were evaluated by Kaplan-Meier survival analysis and Cox regression survival analysis.Odds ratio,hazard ratio(HR),median overall survival time(MST),median tumor recurrence-free survival time(MRT),and corresponding 95%confidential interval(CI)was calculated to RESULTS Kaplan-Meier survival analysis showed that compared with high TIMP3 expression,low TIMP3 expression in tumor tissues significantly decreased the MST(36.00 mo vs 18.00 mo)and MRT(32.00 mo vs 16 mo)of patients with AHCC.Multivariate Cox regression survival analysis further proved that decreased expression of TIMP3 increased the risk of death(HR=2.85,95%CI:2.04-4.00)and tumor recurrence(HR=2.26,95%CI:1.57-3.26).Furthermore,decreased expression of TIMP3 protein in tissues with AHCC was significantly correlated with tumor clinicopatho-logical features,such as tumor size,tumor grade and stage,tumor microvessel density,and tumor blood invasion.Additionally,TIMP3 protein expression was also negatively associated with amount of AFB1-DNA adducts in tumor tissues.CONCLUSION These findings indicate that the dysregulation of TIMP3 expression is related to AHCC biological behaviors and affects tumor outcome,suggesting that TIMP3 may act as a prognostic biomarker for AHCC.
